Funded Tech Companies
Neotropix
Wondering who backed Neotropix? Aurora Funds, Quaker Partners and private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Neotropix
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
351 Phoenixville Pike
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Company Background Information
Overview
Neotropix is an early stage drug discovery company dedicated to the research, development and commercialization of virus-based therapies for the treatment of cancer. Founded in 2003, Neotropix is developing oncolytic virotherapies to treat several of the most aggressive and deadly forms of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2010
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Lanciano
Chief Scientific Officer
Paul Hallenbeck
Company Investors
- Aurora Funds (Christopher Kroeger)
- Quaker Partners (Matthew Rieke)
- VIMAC Ventures (Sena Biswas)
- Battery Ventures (Avi Domoshevizki)
- Gemini Israel Funds (Adi Pundak-Mintz)
- Novartis BioVenture Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs